Driehaus Capital Management’s Rapport Therapeutics RAPP Stock Holding History
Bought
Maintained
Sold
Other funds holding RAPP
Driehaus Capital Management's RAPP Position: Q3 2026 in Review
Driehaus Capital Management opened a new position in Rapport Therapeutics (RAPP) in Q3 2026: 21,567 shares worth $725K. The stake represents 0.01% of the portfolio and ranks #385 among its holdings. This is a return to the name: Driehaus Capital Management previously reported a position in RAPP as recently as Q2 2025.
Driehaus Capital Management first reported a position in RAPP in Q2 2025 and has held it in 2 quarters since. The position peaked at $1.49M in Q2 2025. 169 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.
- Driehaus Capital Management held 21,567 shares of Rapport Therapeutics worth $725K as of Q3 2026.
- Rapport Therapeutics was a new Driehaus Capital Management position in Q3 2026.
- Rapport Therapeutics made up 0.01% of Driehaus Capital Management's portfolio in Q3 2026, its #385 holding.
- Driehaus Capital Management first reported a position in Rapport Therapeutics in Q2 2025 and has held it in 2 quarters since.
- Driehaus Capital Management's Rapport Therapeutics position peaked at $1.49M in Q2 2025.
- 169 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.
Based on Driehaus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.